<?xml version="1.0" encoding="UTF-8"?><!-- Converted from Majour with majour2a++ V1.11 --><!--Automatically converted from version 2.3 to 2.4--><!DOCTYPE Publisher PUBLIC "-//Springer-Verlag//DTD A++ V2.4//EN" "http://devel.springer.de/A++/V2.4/DTD/A++V2.4.dtd">
<Publisher>
   <PublisherInfo>
      <PublisherName>Springer-Verlag</PublisherName>
      <PublisherLocation>Berlin/Heidelberg</PublisherLocation>
   </PublisherInfo>
   <Journal>
      <JournalInfo JournalProductType="Legacy" NumberingStyle="Unnumbered">
         <JournalID>401</JournalID>
         <JournalPrintISSN>0001-6322</JournalPrintISSN>
         <JournalElectronicISSN>1432-0533</JournalElectronicISSN>
         <JournalSPIN/>
         <JournalTitle>Acta Neuropathologica</JournalTitle>
         <JournalSubTitle/>
         <JournalAbbreviatedTitle>Acta Neuropathol</JournalAbbreviatedTitle>
<JournalSubjectGroup>
<JournalSubject Type="Primary">Legacy</JournalSubject>
</JournalSubjectGroup>
      </JournalInfo>
      <Volume>
         <VolumeInfo VolumeType="Regular">
<VolumeIDStart>101</VolumeIDStart>
<VolumeIDEnd>101</VolumeIDEnd>
<VolumeIssueCount/>
</VolumeInfo>
         <Issue IssueType="Regular">
            <IssueInfo TocLevels="0">
               <IssueIDStart>3</IssueIDStart>
               <IssueIDEnd>3</IssueIDEnd>
               <IssueHistory>
                  <OnlineDate>
                     <Year>2001</Year>
                     <Month>2</Month>
                     <Day>9</Day>
                  </OnlineDate>
                  <PrintDate>
                     <Year>2001</Year>
                     <Month>3</Month>
                     <Day/>
                  </PrintDate>
                  <CoverDate>
                     <Year>2001</Year>
                     <Month>3</Month>
                  </CoverDate>
               </IssueHistory>
               <IssueCopyright>
                  <CopyrightHolderName>Springer-Verlag</CopyrightHolderName>
                  <CopyrightYear>2001</CopyrightYear>
               </IssueCopyright>
            </IssueInfo>
            <Article ID="Art1">
               <ArticleInfo ArticleType="OriginalPaper" ContainsESM="No" Language="En" NumberingStyle="Unnumbered" TocLevels="0">
                  <ArticleID>00343</ArticleID>
                  <ArticleDOI>10.1007/s004010000343</ArticleDOI>
                  <ArticleTitle Language="En">Promoter hypermethylation and homozygous deletion of the<Emphasis Type="Italic"> p14</Emphasis>
                     <Superscript>
                        <Emphasis Type="Italic">ARF</Emphasis>
                     </Superscript> and<Emphasis Type="Italic"> p16</Emphasis>
                     <Superscript>
                        <Emphasis Type="Italic">INK4a</Emphasis>
                     </Superscript> genes in oligodendrogliomas</ArticleTitle>
                  <ArticleCategory>Express Communication</ArticleCategory>
                  <ArticleFirstPage>185</ArticleFirstPage>
                  <ArticleLastPage>189</ArticleLastPage>
                  <ArticleHistory>
                     <Received>
                        <Year>2000</Year>
                        <Month>09</Month>
                        <Day>26</Day>
                     </Received>
                  </ArticleHistory>
                  <ArticleCopyright>
                     <CopyrightHolderName>Springer-Verlag</CopyrightHolderName>
                     <CopyrightYear>2001</CopyrightYear>
                  </ArticleCopyright>
<ArticleGrants>
<MetadataGrant Grant="OpenAccess"/>
<AbstractGrant Grant="OpenAccess"/>
<BodyPDFGrant Grant="Restricted"/>
<BodyHTMLGrant Grant="Restricted"/>
<BibliographyGrant Grant="Restricted"/>
<ESMGrant Grant="Restricted"/>
</ArticleGrants>
               </ArticleInfo>
               <ArticleHeader>
                  <AuthorGroup>
                     <Author AffiliationIDS="A1">
                        <AuthorName DisplayOrder="Western">
                           <GivenName>Takao</GivenName>
                           <FamilyName>Watanabe</FamilyName>
                        </AuthorName>
                     </Author>
                     <Author AffiliationIDS="A1">
                        <AuthorName DisplayOrder="Western">
                           <GivenName>Mitsutoshi</GivenName>
                           <FamilyName>Nakamura</FamilyName>
                        </AuthorName>
                     </Author>
                     <Author AffiliationIDS="A2">
                        <AuthorName DisplayOrder="Western">
                           <GivenName>Yasuhiro</GivenName>
                           <FamilyName>Yonekawa</FamilyName>
                        </AuthorName>
                     </Author>
                     <Author AffiliationIDS="A1">
                        <AuthorName DisplayOrder="Western">
                           <GivenName>Paul</GivenName>
                           <FamilyName>Kleihues</FamilyName>
                        </AuthorName>
                     </Author>
                     <Author AffiliationIDS="A1">
                        <AuthorName DisplayOrder="Western">
                           <GivenName>Hiroko</GivenName>
                           <FamilyName>Ohgaki</FamilyName>
                        </AuthorName>
                        <Contact>
                           <Phone>+33-472-738534</Phone>
                           <Email>ohgaki@iarc.fr</Email>
                        </Contact>
                     </Author>
                     <Affiliation ID="A1">
                        <OrgName>Unit of Molecular Pathology, International Agency for Research on Cancer, 150 cours Albert Thomas, 69372 Lyon Cedex 08, France</OrgName>
                        <OrgAddress>
                           <Street/>
                           <Postbox/>
                           <Postcode/>
                           <City/>
                           <State/>
                        </OrgAddress>
                     </Affiliation>
                     <Affiliation ID="A2">
                        <OrgName>Department of Neurosurgery, University Hospital, 8091 Zurich, Switzerland</OrgName>
                        <OrgAddress>
                           <Street/>
                           <Postbox/>
                           <Postcode/>
                           <City/>
                           <State/>
                        </OrgAddress>
                     </Affiliation>
                  </AuthorGroup>
                  <Abstract ID="Abs1" Language="En">
                     <Heading>Abstract.</Heading>
                     <Para> The<Emphasis Type="Italic"> INK4a</Emphasis>/<Emphasis Type="Italic">ARF</Emphasis> locus on chromosome 9p21 encodes two gene products that are involved in cell cycle regulation through inhibition of CDK4-mediated<Emphasis Type="Italic"> RB</Emphasis> phosphorylation (p16<Superscript>INK4a</Superscript>) and binding to MDM2 leading to p53 stabilization (p14<Superscript>ARF</Superscript>). The locus is deleted in up to 25% of oligodendrogliomas and 50% of anaplastic oligodendrogliomas, but little is known on the frequency of gene silencing by DNA methylation. We assessed promoter hypermethylation of<Emphasis Type="Italic"> p14</Emphasis>
                        <Superscript>
                           <Emphasis Type="Italic">ARF</Emphasis>
                        </Superscript> and<Emphasis Type="Italic"> p16</Emphasis>
                        <Superscript>
                           <Emphasis Type="Italic">INK4a</Emphasis>
                        </Superscript> using methylation-specific PCR, and homozygous deletion of the<Emphasis Type="Italic"> p14</Emphasis>
                        <Superscript>
                           <Emphasis Type="Italic">ARF</Emphasis>
                        </Superscript> and<Emphasis Type="Italic"> p16</Emphasis>
                        <Superscript>
                           <Emphasis Type="Italic">INK4a</Emphasis>
                        </Superscript> genes by differential PCR in 29 oligodendrogliomas (WHO grade II) and 20 anaplastic oligodendrogliomas (WHO grade III). Promoter hypermethylation of the<Emphasis Type="Italic"> p14</Emphasis>
                        <Superscript>
                           <Emphasis Type="Italic">ARF</Emphasis>
                        </Superscript> gene was detected in 6/29 (21%) oligodendrogliomas and 3/20 (15%) anaplastic oligodendrogliomas. None of the oligodendrogliomas and only 1 out of 20 anaplastic oligodendrogliomas showed hypermethylation of<Emphasis Type="Italic"> p16</Emphasis>
                        <Superscript>
                           <Emphasis Type="Italic">INK4a</Emphasis>
                        </Superscript>. Homozygous deletion was not detected in any of the WHO grade II oligodendrogliomas but was present in 5/20 (25%) anaplastic oligodendrogliomas and always affected both genes. In one tumor containing distinct areas with and without anaplasia,<Emphasis Type="Italic"> p14</Emphasis>
                        <Superscript>
                           <Emphasis Type="Italic">ARF</Emphasis>
                        </Superscript> hypermethylation was detected in the WHO grade II area, while homozygous co-deletion of<Emphasis Type="Italic"> p14</Emphasis>
                        <Superscript>
                           <Emphasis Type="Italic">ARF</Emphasis>
                        </Superscript> and<Emphasis Type="Italic"> p16</Emphasis>
                        <Superscript>
                           <Emphasis Type="Italic">INK4a</Emphasis>
                        </Superscript> was found in the region with anaplastic features (grade III). These data suggest that aberrant<Emphasis Type="Italic"> p14</Emphasis>
                        <Superscript>
                           <Emphasis Type="Italic">ARF</Emphasis>
                        </Superscript> expression due to hypermethylation is the earliest<Emphasis Type="Italic"> INK4a</Emphasis>/<Emphasis Type="Italic">ARF</Emphasis> change in the evolution of oligodendrogliomas, while the presence of<Emphasis Type="Italic"> p14</Emphasis>
                        <Superscript>
                           <Emphasis Type="Italic">ARF</Emphasis>
                        </Superscript> and<Emphasis Type="Italic"> p16</Emphasis>
                        <Superscript>
                           <Emphasis Type="Italic">INK4a</Emphasis>
                        </Superscript> deletions indicates progression to anaplastic oligodendroglioma.</Para>
                  </Abstract>
                  <KeywordGroup Language="En">
                     <Keyword>p16INK4a p14ARF Homozygous deletion Promoter hypermethylation Oligodendroglioma</Keyword>
                  </KeywordGroup>
                  <ArticleNote Type="Misc">
                     <SimplePara>Revised, accepted: 22 November 2000</SimplePara>
                  </ArticleNote>
                  <ArticleNote Type="Misc">
                     <SimplePara>Electronic Publication</SimplePara>
                  </ArticleNote>
               </ArticleHeader>
               <BodyRef FileRef="BodyRef/PDF/401_2001_Article_343.pdf" TargetType="PDF"/>
            </Article>
         </Issue>
      </Volume>
   </Journal>
</Publisher>